Features Screener Stocks Charts
Sign In Sign Up

Lal PathLabs Financial Statements

NSE: LALPATHLAB | BSE: 539524 | HEALTHCARE

Showing 5 of 10 years of data. Sign up free for the full 10 years of history.

View Plans

Lal PathLabs (LALPATHLAB) reported revenue of ₹24.61B in FY2025 with net income of ₹4.87B. Total assets stood at ₹27.17B and free cash flow was ₹5.25B.

Lal PathLabs Income Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025
Item Chart 2021 2022 2023 2024 2025
Revenue 16.33B 21.40B 20.59B 22.96B 24.61B
Cost of Rev. -6.02B -5.02B -4.47B -4.51B -8.23B
Gross Profit 10.31B 16.38B 16.11B 18.44B 16.38B
SGA -5.43B -10.24B -10.80B -11.66B -4.82B
Op. Income 4.10B 5.05B 3.81B 5.35B 5.54B
PBT 3.94B 4.75B 3.44B 5.06B 6.25B
Net Income 2.92B 3.50B 2.41B 3.62B 4.87B
Dil. Shares 165.48M 165.89M 166.24M 166.47M 166.84M
Diluted EPS 17.62 20.79 14.37 21.49 29.20

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Lal PathLabs's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Lal PathLabs Balance Sheet

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025
Item Chart 2021 2022 2023 2024 2025
Curr. assets 11.45B 8.75B 9.73B 11.27B 13.64B
Non-curr. assets 5.16B 14.72B 14.12B 13.29B 13.53B
Total assets 16.61B 23.47B 23.86B 24.56B 27.17B
Curr. liabilities 2.74B 5.00B 4.70B 4.64B 4.02B
Non-curr. liab. 1.11B 3.10B 2.16B 1.07B 1.08B
Total liabilities 3.85B 8.10B 6.86B 5.71B 5.10B
Total equity 12.76B 15.37B 17.00B 18.85B 22.06B
Total liab. & eq. 16.61B 23.47B 23.86B 24.56B 27.17B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Lal PathLabs's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Lal PathLabs Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025
Item Chart 2021 2022 2023 2024 2025
Net Income 2.96B 3.50B 2.41B 3.62B 4.92B
Operating CF 3.98B 4.47B 4.56B 5.35B 5.69B
Capex -355.64M -941.06M -365.15M -511.67M -442.94M
Investing CF -2.12B -4.49B -2.87B -242.69M -3.03B
Dividend Paid -994.83M -1.17B -1.03B -2.01B -2.07B
Financing CF -1.39B 1.36B -2.83B -4.14B -3.34B
Cash (start) 1.97B 2.44B 3.78B 2.64B 3.61B
Cash (end) 2.44B 3.78B 2.64B 3.61B 2.93B
FCF 3.63B 3.53B 4.20B 4.84B 5.25B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Lal PathLabs's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025

Related Stocks